← FDA Drug Approvals (Drugs@FDA)

BKEMV

BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2024-05-28

Drug application

FDA Application #
BLA761333
Application type
Biologics License Application
Brand name
BKEMV
Generic name
ECULIZUMAB-AEEB
Active ingredients
ECULIZUMAB-AEEB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AMGEN INC
Manufacturer
Amgen Inc
First approval
2024-05-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown